Product Details

Velsipity

Etrasimod
2 mg
Tablet


DIN/PIN/NPN

02544903

Manufacturer

Pfizer Canada Inc.

Formulary Listing Date

2025-10-20  

Unit Price

43.1000

Amount MOH Pays

43.1000

Coverage Status

Exceptional Access Program Product

ODB Formulary Therapeutic Classification

Therapeutic Note

NO

ATC Code

L04AE05

Interchangeable Products

NO  

LU Clinical Criteria

NO  

Requirements


EAP Criteria

 
Therapeutic Class Reimbursement Criteria
Unclassified EAP Drugs

These drugs are not currently listed in the Exceptional Access Program Reimbursement Criteria for Frequently Requested Drugs – January 1, 2025 Edition

Physicians may wish to contact the EAP directly by phone at 416-327-8109 or 1-866-811-9893 or by email at EAPFeedback.MOH@ontario.ca to see if an unlisted drug product and/or indication may be considered for EAP funding.

Product Monograph

View Monograph